Michael E. Petrone

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial

Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor et al. · Journal of Clinical Oncology · 2009 · 341 citations · Full text

Medicine, Oncology, Pharmacology +13

A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia

Shyamala Navada, Steven Fruchtman, Rosalie Odchimar-Reissig et al. · Leukemia Research · 2017 · 43 citations

Medicine, Hematology, Pharmacology +14

The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail

Christopher R. Cogle, Sandra Kurtin, Tanya G. K. Bentley et al. · The Oncologist · 2017 · 21 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation

William J. Lane, Koichi Hattori, Sérgio Dias et al. · Experimental Hematology · 2001 · 18 citations

Medicine, Hematology, Pharmacology +13

Satraplatin, an Oral Platinum, Administered on a Five-day Every-Five-Week Schedule: a Pharmacokinetic and Food Effect Study

Alejandro D. Ricart, John Sarantopoulos, Emiliano Calvo et al. · Clinical Cancer Research · 2009 · 15 citations

Medicine, Oncology, Pharmacology +17